 |
|
|
 |
|
Rationale:
- Continuous monitoring during the rewarming of hypothermic patients will allow for early diagnosis and implementation of appropriate
therapy to treat afterdrop, acidosis, or hemodynamic instability.
|
|
Evidence:
- Pathophysiologic effects of hypothermia and its complications can be life threatening and may require immediate intervention.
Such interventions may include cardioversion for malignant ventricular arrhythmias, intubation and mechanical ventilation
for respiratory failure, inotropic support for cardiogenic failure, dialysis for renal failure, and invasive rewarming strategies
(37; 112; 138; 139).
|
|
Comments:
- Caution must be applied to the use of inotropic support in moderate to severe hypothermia. The rat model suggests that there
may be differences in cardiac and vascular responsiveness to epinephrine during hypothermia compared to normothermia. Hypothermic
rats that were given low-dose epinephrine (0.125 µg/min) during rewarming from 28°C (82.4°F) experienced a significant improvement
in cardiac output, whereas the cardiac output remained unchanged compared to controls in rats given high-dose epinephrine
(1.25 µg/min). During hypothermia, the increase in systemic vascular resistance produced by high-dose epinephrine appears
to counteract its effect on cardiac inotropy (140).
- In canine models, even mild hypothermia depresses left ventricular diastolic function. Rapid intravenous infusion of warmed
fluids could precipitate pulmonary edema in hypothermic patients, especially those who, through advanced age or long-standing
hypertension, have underlying impaired ventricular compliance (141).
- A growing body of experimental data from laboratory animals suggest that mild hypothermia (approximately 33°C [91.4°F]) is
neuroprotective in traumatic brain injury when achieved rapidly following the insult. However, the extent of neuroprotection
also depends on the rate of rewarming following therapeutic hypothermia, with slow rewarming resulting in better outcomes.
The neuroprotective effect of hypothermia combined with slow rewarming has been shown for contusion volume (142), responsiveness of the cerebral microcirculation (143), and the extent of axonal injury (144).
|
| FAQs |
|
|
|
Albert Cheung, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Dmitri Guvakov, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Stuart Weiss, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Wenjun Zhou Martini, PhD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for
continuing medical education grand rounds and lectures given.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|